Klinische Relevanz zirkulierender Mammakarzinomzellen
作者： T. Fehm , M. Banys , F. Meier-Stiegen , A. Hartkopf , V. Müller
DOI: 10.1007/S00129-012-3015-8
关键词:
摘要: Isolierte Tumorzellen konnen sowohl im peripheren Blut als auch Knochenmark (KM) von Patientinnen mit Mammakarzinom detektiert werden. Wahrend der Nachweis disseminierten (DTZ) primaren Mammakarzinompatientinnen einen unabhangigen Prognosefaktor (Level-I-Evidenz) darstellt, ist die prognostische Bedeutung zirkulierenden (ZTZ) in diesem Kollektiv noch nicht eindeutig geklart. Im Beitrag werden Relevanz ZTZ beim wie metastasierten und aktuelle Studienlage zu Thema erlautert.
springer.com
core.ac.uk
sci-hub.se 参考文章(35)
智 小林, 隆 佐々木, ASCO Annual Meeting 2012 膵・胆道癌frontier. ,vol. 2, pp. 116- 121 ,(2012)
BK Rack, C Schindlbeck, U Andergassen, A Schneeweiss, T Zwingers, W Lichtenegger, M Beckmann, HL Sommer, K Pantel, W Janni, SUCCESS Study Group, None, Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial. Journal of Clinical Oncology. ,vol. 28, pp. 1003- 1003 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.1003
F.-C. Bidard, C. Mathiot, S. Delaloge, E. Brain, S. Giachetti, P. de Cremoux, M. Marty, J.-Y. Pierga, Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer Annals of Oncology. ,vol. 21, pp. 729- 733 ,(2010) , 10.1093/ANNONC/MDP391
Malgorzata Banys, Natalia Krawczyk, Sven Becker, Jolanta Jakubowska, Annette Staebler, Diethelm Wallwiener, Tanja Fehm, Ralf Rothmund, The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer Breast Cancer Research and Treatment. ,vol. 132, pp. 121- 129 ,(2012) , 10.1007/S10549-011-1569-0
A Daskalaki, S Agelaki, M Perraki, S Apostolaki, N Xenidis, E Stathopoulos, E Kontopodis, D Hatzidaki, D Mavroudis, V Georgoulias, Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer British Journal of Cancer. ,vol. 101, pp. 589- 597 ,(2009) , 10.1038/SJ.BJC.6605183
Mitra Tewes, Bahriye Aktas, Anja Welt, Siemke Mueller, Siegfried Hauch, Rainer Kimmig, Sabine Kasimir-Bauer, Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies Breast Cancer Research and Treatment. ,vol. 115, pp. 581- 590 ,(2009) , 10.1007/S10549-008-0143-X
Janet Fricker, San Antonio Breast Cancer Symposium. Lancet Oncology. ,vol. 10, pp. 20- ,(2009) , 10.1016/S1470-2045(08)70329-2
T. Fehm, E.F. Solomayer, S. Meng, T. Tucker, N. Lane, J. Wang, G. Gebauer, Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells Cytotherapy. ,vol. 7, pp. 171- 185 ,(2005) , 10.1080/14653240510027082
B Rack, C Schindlbeck, U Andergassen, R Lorenz, T Zwingers, A Schneeweiss, W Lichtenegger, MW Beckmann, H Sommer, K Pantel, K Friese, W Janni, Abstract S6-5: Prognostic Relevance of Circulating Tumor Cells in the Peripheral Blood of Primary Breast Cancer Patients Cancer Research. ,vol. 70, ,(2010) , 10.1158/0008-5472.SABCS10-S6-5
Michail Ignatiadis, Maria Perraki, Stella Apostolaki, Eleni Politaki, Nikos Xenidis, Maria Kafousi, Efstathios Stathopoulos, Evi Lianidou, Christos Sotiriou, Vassilis Georgoulias, Dimitris Mavroudis, None, Molecular Detection and Prognostic Value of Circulating Cytokeratin-19 Messenger RNA–Positive and HER2 Messenger RNA–Positive Cells in the Peripheral Blood of Women with Early-Stage Breast Cancer Clinical Breast Cancer. ,vol. 7, pp. 883- 889 ,(2007) , 10.3816/CBC.2007.N.054